Patents by Inventor Jens Peter Norgaard

Jens Peter Norgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963995
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: April 23, 2024
    Assignee: Ferring B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20220118046
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: May 27, 2021
    Publication date: April 21, 2022
    Applicant: Ferring B.V.
    Inventors: Bjarke Mirner KLEIN, Jens Peter NORGAARD
  • Patent number: 11020448
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: June 1, 2021
    Assignee: FERRING B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20190134146
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: October 17, 2018
    Publication date: May 9, 2019
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Patent number: 10137167
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: November 27, 2018
    Assignee: Ferring B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20180250357
    Abstract: The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.
    Type: Application
    Filed: January 26, 2018
    Publication date: September 6, 2018
    Inventors: Bjarke M. Klein, Jens Peter Norgaard, Brad Shumel
  • Patent number: 9974826
    Abstract: The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: May 22, 2018
    Assignee: Ferring B.V.
    Inventors: Bjarke Mimer Klein, Jens Peter Norgaard, Brad Shumel
  • Publication number: 20140113863
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: December 30, 2013
    Publication date: April 24, 2014
    Applicant: Ferring B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20100286045
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: March 25, 2010
    Publication date: November 11, 2010
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20090291880
    Abstract: The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.
    Type: Application
    Filed: May 21, 2009
    Publication date: November 26, 2009
    Inventors: Bjarke Mimer Klein, Jens Peter Norgaard, Brad Shumel